Send to

Choose Destination
See comment in PubMed Commons below
J Pharm Biomed Anal. 2007 Jan 17;43(2):788-92. Epub 2006 Sep 18.

Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients.

Author information

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Sask. S7N5C9, Canada.


A selective and highly accurate HPLC-UV method is described to determine plasma concentrations of mycophenolic acid (MPA), the active metabolite of the prodrugs Cellcept and Myfortic. The method is simple and utilizes acidification of plasma and protein precipitation step using a mixture of acetonitrile and phosphate buffer (pH 3). Following vortex mixing and centrifugation, the supernatant (50 microL) was injected onto a Zorbax Eclipse XDB C(18) column (150 mm x 4.6 mm I.D., 5 microm particle size). A mobile phase composed of acetonitrile and 0.1 M phosphate buffer, pH 3 (43:57) delivered at 1.0 mL/min produced peaks for MPA and the internal standard (Naproxen) in <7 min. Calibration curves were linear (r(2)>0.994) from 1.0-40 microg/mL with intra- and inter-day precision <15% and accuracy >95%. The method's improved sensitivity (LOQ=1.0 microg/mL) and minimal sample processing allowed rapid monitoring of MPA in human plasma.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center